TRISH releases its scheduled space-health briefing on Blue Origin and spaceflight risk on October 13, 2026.

Question

Six frontier AI models put this at 78% by 15 Oct 2026. Full reasoning from every model.

WillHappen.ai · Accepted Answer

78% — the median of 6 frontier models, resolving by 2026-10-15.

Answer

Gemini (Google): 88% — Pre-scheduled institutional research briefings facing no regulatory blocks rarely reschedule five days out. TRISH operates on academic and NASA grant timelines where scheduled public webinars and briefings adhere strictly to dates. Short-notice cancellations typically stem from speaker emergencies or technical failures, which historically affect under 15% of events. A formal postponement notice posted on the TRISH or Baylor College of Medicine portal before October 13 would reverse this outlook.

Answer

Claude (Anthropic): 55% — Whether TRISH keeps this specific calendar date without delay or reschedule over the next week. Scheduled institutional briefings often slip by days or weeks due to speaker or logistics changes, even when announced. No strong evidence yet confirming firm commitment closer to the date, and five days is a short window to verify. If TRISH or Blue Origin publicly confirms the agenda within the next few days, confidence would rise significantly.

Answer

GPT (OpenAI): 78% — This chiefly depends on whether Blue Origin and TRISH keep a calendar commitment only five days away. A named October 13 briefing is already scheduled, and public research events usually proceed absent a speaker, launch, or logistics disruption. TRISH and Blue Origin need only deliver or host the event; no regulator, funding vote, or technical milestone must clear first. I would cut this sharply if either organization removes the listing or reports a speaker, travel, or operations conflict before October 13.

Answer

Grok (xAI): 82% — Whether TRISH actually hosts the listed Oct 13 briefing rather than postponing. TRISH event calendars almost never slip inside a five-day window unless a partner (NASA/Blue Origin) withdraws. Announced institute webinars historically run on the posted date ~90 percent of the time. A public cancellation notice before the 13th would be the only development that reverses the forecast.

Answer

DeepSeek (DeepSeek): 72% — TRISH has a scheduled item five days out; the question is whether it slips or gets cancelled. TRISH (Baylor-based, NASA-funded) routinely posts its seminar and briefing schedule weeks ahead, and items already on the calendar usually run on time. Five days is short enough that cancellation would require a specific trigger — a NASA shutdown, speaker withdrawal, or a schedule shift — none of which is currently… Base rate for scheduled institutional webinars/briefings going off as planned is roughly 80-90%; TRISH's small-team operation and occasional rescheduling puts this…

Answer

Qwen (Alibaba): 78% — TRISH has a public calendar commitment; the main risk is a quiet slip or cancellation, not a failure to produce content. TRISH is a NASA-funded institute with institutional pressure to deliver scheduled public-facing briefings; cancellations without rescheduling are rare. The event is only 5 days out, meaning materials are almost certainly finalized; last-minute cancellations at this stage are uncommon for research institutes. A delay or postponement (rather than outright cancellation) would still resolve NO under the literal wording, which is the main downside scenario.

TRISH releases its scheduled space-health briefing on Blue Origin and spaceflight risk on October 13, 2026.

An FDA-approved treatment that halts or reverses cognitive decline in Alzheimer's disease becomes available before 2036.

A broad-spectrum curative therapy for metastatic solid tumors is approved before 2035.

An mRNA-based therapeutic cancer vaccine receives full FDA approval for curative intent before 2032.

A definitive cure for at least three of the top five deadliest cancers is approved before 2040.